Regulators clear Orthocell’s nerve repair product for sale in Canada
Following news last week that it has begun appointing distributors for Remplir in the United States, Orthocell has announced clearance to begin selling the nerve repair product in Canada, a market it estimates to be worth $US 75 million. In an ASX statement on Wednesday, Orthocell said it has received a Medical Device Licence (MDL)…
